MA-EXCEL-DRYER
30.6.2020 22:17:10 CEST | Business Wire | Press release
The topic of hygiene has come to the forefront in mainstream media as reopening plans are introduced around the globe. While leading health organizations like the World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC), recommend the use of hand dryers, misinformation about them remains online, and continues to be quoted and perpetuated. Leaders from Excel Dryer , manufacturer of XLERATOR® Hand Dryers, wish to deliver a message to educate the professionals, consultants and government officials who are creating reopening guidelines, and the general public, especially in times of COVID-19: Excel hand dryers are a safe, hygienic touchless solution and an effective way to achieve completely dry hands, a critical part of proper hand hygiene , the top defense against the spread of germs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200630006010/en/
Kelly Reynolds, Ph.D., Professor and Department Chair at the Mel & Enid Zuckerman College of Public Health at the University of Arizona, offered an explanation as to the root of these misconceptions, stating that, “Consumers may only read [sensationalized] headlines which can influence public opinion toward biased or erroneous conclusions, [but] the fact is, the breadth of data available does not favor one hand drying method as being more hygienic or safer.”
Excel hand dryers provide a touchless hand drying solution to help prevent potential cross-contamination between restroom surfaces and wet hands. All dryers in Excel’s line are hygienic, but dryers with HEPA have been proven to add another level of protection. Viral efficiency testing conducted by the preeminent independent air media and filter testing company, LMS Technologies in April of 2020 found that XLERATOR® , XLERATOReco ® and XLERATORsync® Hand Dryers with HEPA Filtration Systems remove 99.999 percent of viruses from the airstream.
William Gagnon, vice president of marketing and sales at Excel Dryer, wishes to correct misinformation and biases about hand dryers. “Hand dryers are hygienic and have been used to properly dry hands for decades. In addition to top health organizations recommending their use, hand dryers also provide significant benefits over paper that are undisputable. For example, our recent test results prove XLERATOR hand dryers with HEPA Filtration Systems remove 99.999 percent of viruses from the airstream, something paper will never be able to do.”
Conversely, paper towels may not be as hygienic as the public believes. One independent study showed 17 species of bacteria on unused, recycled paper towels , including Bacillus, which can cause food poisoning. After their use, damp paper towels are a breeding ground for viruses and bacteria in and around trash receptacles and can be used to clog toilets and sinks creating a very unhygienic restroom environment. If the paper towels are out of stock, visitors cannot dry their hands at all, and wet hands have been shown to be 1,000 times more likely to transfer germs than dry hands .
Gagnon concluded, “I encourage members of the public and those individuals charged with the creation of guidelines, reopening plans or facilities operations, to dive deeper into news articles and hygiene studies rather than simply believing sensationalized, click-bait headlines born from biased results. Hand dryers are safe and hygienic. They dry hands completely, and are a top defense against the spread of germs.”
About Excel Dryer, Inc.
Excel Dryer has been manufacturing the finest American-made hand dryers for more than 50 years. The family-owned and -operated company revolutionized the industry with the invention of the patented XLERATOR® Hand Dryer that created the high-speed, energy-efficient hand dryer category and set a new standard for performance, reliability and customer satisfaction. Excel Dryer prides itself on offering the best customer service and making hygienic, cost-effective and sustainable products people can depend on. Available for distribution worldwide, Excel Dryer products can be purchased through an established network of sales representatives who call on more than 5,000 distributors globally. Learn more about Excel Dryer at exceldryer.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200630006010/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
